| IOVANCE BIOTHERAPEUTICS |
| USA |
| Gesundheit |
| US4622601007 / A2DT49 |
| 2LB (Frankfurt) / IOVA (NASDAQ) |
| FRA:2LB, ETR:2LB, 2LB:GR, NASDAQ:IOVA |
| - |
| https://www.iovance.com/ |
|
Iovance Biotherapeutics, Inc. is a commercial-stag..
>Volltext.. |
| 568.71 Mio. EUR |
| 358.63 Mio. EUR |
| 209.72 Mio. EUR |
| -316.76 Mio. EUR |
| -338.58 Mio. EUR |
| -1.07 EUR |
| 46.17 Mio. EUR |
| 115.03 Mio. EUR |
| -263.46 Mio. EUR |
| 2.33 |
| 570.12% |
| 19.46% |
| - |
| - |
| - |
| - |
| IOVANCE |
| 06.11.25 |
|
||||
|
||||
|
||||
|
||||
|